Rent-a rep company PDI said on Friday said it expected significant reductions in the number of drug reps it contracts with AstraZeneca.
The reductions came as part of discussions with AstraZeneca over the status of fees for service contract sales engagements.
PDI, has about 800 "cheerleaders" under contract with AstraZeneca.
They say they will comment further once they have more information about the scope and timing of the changes.
Insiders' view: We will see a lot more of this going on, together with "stealth" shedding of reps using "micro-management techniques". CafePharma is a fair barometer of rep (dis)contentment.
Source: Reuters
No comments:
Post a Comment